serena williams promoting glp-1 π Inside Williamsβ partnership with @ro.co for GLP-1s, Itβs a grand slam partnership for telehealth provider Ro. World renowned tennis star @serenawilliams is partnering with the brand as its Serena Williams on Why She
Description
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

When we look at peoples total fruit or vegetable consumption, or at other individual fruits such as apples or bananas, we dont see any relationship between intake and risk of depression. Last but not least, exercise continues to emerge as an important factor in protecting brain and mental health
What about tweakments can they help

Her case reflects the other plaintiffs claims that semaglutide use led to gastrointestinal conditions requiring treatment

Protein shakes designed for GLP-1 users offer a convenient way to maintain intake when appetite is heavily suppressed
If you want to see whether a medically supervised program is a better fit for your goals, you can take the free assessment quiz
